Specifically, the algal oil has an EPA:DHA ratio of 1.5 : 1.
Dsm-Firmenich (Kaiseraugst, Switzerland) will soon launch an algae-based oil in North America that it says offers the same EPA:DHA ratio as standard fish oil does. Specifically, the life’sOMEGA O3O2O algal oil has an EPA:DHA ratio of 1.5 : 1. The company calls it “the first and only single-source algal omega-3 with the same EPA:DHA ratio naturally found in fish oil.”
In addition to providing the same ratio of EPA and DHA as in fish oil, life’sOMEGA O3O2O is also twice as potent as standard fish oil, the firm says. The natural, non-GMO ingredient is manufactured using a proprietary precision fermentation method.
The firm is proposing the ingredient as a sustainable and stable omega-3 source that addresses any limited availability of traditional fish oil. “This highly concentrated plant-based EPA and DHA solution will support greater supply security and help our customers achieve their sustainability goals, especially as life’sOMEGA O3O2O is produced in a controlled and closed environment, with zero impact on marine ecosystems,” said Brent MacDonald, director of global product marketing at Dsm-Firmenich, in a press release.
The ingredient will initially launch in North America “and is expected to achieve regulatory clearance in the U.S. as early as January 2024,” the company states.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.